Boston Scientific Corporation (BSX)

Market Cap	152.68B
Revenue (ttm)	17.55B
Net Income (ttm)	2.03B
Shares Out	1.48B
EPS (ttm)	1.37
PE Ratio	75.30
Forward PE	34.99
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,890,207
Open	104.08
Previous Close	103.86
Day's Range	102.85 - 104.08
52-Week Range	71.88 - 107.53
Beta	0.68
Analysts	Strong Buy
Price Target	112.86 (+9.36%)
Earnings Date	Jul 23, 2025

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 18, 1992
• Country: United States
• Stock Exchange: NYSE
• Ticker Symbol: BSX
• Website: https://www.bostonscientific.com

Financial Performance

In 2024, Boston Scientific's revenue was $16.75 billion, an increase of 17.61% compared to the previous year's $14.24 billion. Earnings were $1.85 billion, an increase of 18.03%.

Analyst Summary

According to 22 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price target is $112.86, which is an increase of 9.36% from the latest price.

Price Target

$112.86

(9.36% upside)

Analyst Consensus: Strong Buy